TVAR live edited broadcasts are safe.

Original title: The impact of live transmition on patients outcomes during transcatheter aortic valve replacement: Results fron the VERITAS study. Reference: Ron Waskman, et al. Cardiovascular Revascularization Medicine 2014;15:63-68

 

With the advancement of medical technology and the great development of telecommunications, performing live or edited cases has become a common occurrence in medical education, but one of the points of discussion was always the safety of these procedures. This is a multicentre, retrospective observational case-control study. The endpoint of this analysis was the safety of patients receiving percutaneous aortic valve replacement (TVAR) during live broadcasts. Valves used were, for femoral access CoreValve and for femoral or apical access, Edwards SAPIEN. Patients receiving TVAR during a live broadcast were compared with a control group using the following criteria; STS ± 2 points, day of the procedure ±4 weeks, same first surgeon and the same access resulting one control group of 46 patients and live stream group of 46 patients. The safety endpoint was evaluated by the rate of major complications: hospital death, stroke, tamponade, embolization, coronary obstruction, renal failure requiring dialysis and need for pacemaker.

No clinical or echocardiographic results from the group live stream versus the control group were observed. The total duration of the procedure was higher in the live broadcast group (129 ± 49 versus 100 ± 42 minutes p = 0.007) but no difference in fluoroscopy time, number of surgeons, intra procedural complications, stay in coronary unit or hospital. The presence of moderate or severe aortic regurgitation was 4.7 % in the live stream group and 9.5 % in the control group without reaching statistical significance. There were no differences in the safety endpoint, death (2.2 % in each group), conversion to surgery, vascular complications, bleeding, arrhythmias, need for pacemaker or dialysis infections.

Conclusion

These data provide support that procedures of percutaneous aortic valve replacement live broadcast for congress made

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...